MicroRNA-125b-5p mediates post-transcriptional regulation of hepatitis B virus replication via the LIN28B/let-7 axis

References

• Ambros V. The functions of animal microRNAs. Nature 2004; 431:350-5; PMID:15372042; https://doi.org/10.1038/nature02871
   PubMed Web of Science ®Google Scholar
• Hammond SM. An overview of microRNAs. Advanced drug delivery reviews 2015; 87:3-14; PMID:25979468; https://doi.org/10.1016/j.addr.2015.05.001
   PubMed Web of Science ®Google Scholar
• Lamontagne J, Steel LF, Bouchard MJ. Hepatitis B virus and microRNAs: Complex interactions affecting hepatitis B virus replication and hepatitis B virus-associated diseases. World J Gastroenterol 2015; 21:7375-99; PMID:26139985; https://doi.org/10.3748/wjg.v21.i24.7375
   PubMed Web of Science ®Google Scholar
• Liu WH, Yeh SH, Chen PJ. Role of microRNAs in hepatitis B virus replication and pathogenesis. Biochim Biophys Acta 2011; 1809:678-85; PMID:21565290; https://doi.org/10.1016/j.bbagrm.2011.04.008
   PubMed Web of Science ®Google Scholar
• Zhang XY, Hou JL, Lu MJ. Regulation of hepatitis B virus replication by epigenetic mechanisms and microRNAs. Front Genet 2013; 4:202; PMID:24133502; https://doi.org/10.3389/fgene.2013.00202
   PubMedGoogle Scholar
• Chen WS, Yen CJ, Chen YJ, Chen JY, Wang LY, Chiu SJ, Shih WL, Ho CY, Wei TT, Pan HL, et al. miRNA-7/21/107 contribute to HBx-induced hepatocellular carcinoma progression through suppression of maspin. Oncotarget 2015; 6:25962-74; PMID:26296971; https://doi.org/10.18632/oncotarget.4504
   PubMed Web of Science ®Google Scholar
• Song K, Han C, Zhang J, Lu D, Dash S, Feitelson M, Lim K, Wu T. Epigenetic regulation of miR-122 by PPARgamma and hepatitis B virus X protein in hepatocellular carcinoma cells. Hepatology 2013; 58:1681-92; PMID:23703729; https://doi.org/10.1002/hep.26514
   PubMed Web of Science ®Google Scholar
• Wei XF, Tan C, Tang CY, Ren GS, Xiang TX, Qiu Z, Liu R, Wu ZJ. Epigenetic repression of miR-132 expression by the hepatitis B virus x protein in hepatitis B virus-related hepatocellular carcinoma. Cell Signal 2013; 25:1037-43; PMID:23376496; https://doi.org/10.1016/j.cellsig.2013.01.019
   PubMed Web of Science ®Google Scholar
• Zhang T, Zhang JP, Cui M, Liu FB, You XN, Du YM, Gao Y, Zhang S, Lu ZP, Ye LH, et al. Hepatitis B Virus X Protein Inhibits Tumor Suppressor miR-205 through Inducing Hypermethylation of miR-205 Promoter to Enhance Carcinogenesis. Neoplasia 2013; 15:1282-+; PMID:24339740; https://doi.org/10.1593/neo.131362
   PubMed Web of Science ®Google Scholar
• Bandopadhyay M, Banerjee A, Sarkar N, Panigrahi R, Datta S, Pal A, Singh SP, Biswas A, Chakrabarti S, Chakravarty R. Tumor suppressor micro RNA miR-145 and onco micro RNAs miR-21 and miR-222 expressions are differentially modulated by Hepatitis B virus X protein in malignant hepatocytes. BMC Cancer 2014; 14:721; PMID:25260533; https://doi.org/10.1186/1471-2407-14-721
   PubMed Web of Science ®Google Scholar
• Li CH, Xu FY, Chow S, Feng L, Yin DL, Ng TB, Chen YC. Hepatitis B virus X protein promotes hepatocellular carcinoma transformation through interleukin-6 activation of microRNA-21 expression. European Journal of Cancer 2014; 50:2560-9; PMID:25087183; https://doi.org/10.1016/j.ejca.2014.07.008
   PubMed Web of Science ®Google Scholar
• Wu CS, Yen CJ, Chou RH, Chen JN, Huang WC, Wu CY, Yu YL. Downregulation of microRNA-15b by hepatitis B virus X enhances hepatocellular carcinoma proliferation via fucosyltransferase 2-induced Globo H expression. International Journal of Cancer 2014; 134:1638-47; PMID:24122375; https://doi.org/10.1002/ijc.28501
   PubMed Web of Science ®Google Scholar
• Potenza N, Papa U, Mosca N, Zerbini F, Nobile V, Russo A. Human microRNA hsa-miR-125a-5p interferes with expression of hepatitis B virus surface antigen. Nucleic Acids Res 2011; 39:5157-63; PMID:21317190; https://doi.org/10.1093/nar/gkr067
   PubMed Web of Science ®Google Scholar
• Wang YL, Jiang L, Ji X, Yang B, Zhang Y, Fu XD. Hepatitis B viral RNA directly mediates down-regulation of the tumor suppressor microRNA miR-15a/miR-16-1 in hepatocytes. J Biol Chem 2013; 288:18484-93; PMID:23649629; https://doi.org/10.1074/jbc.M113.458158
   PubMed Web of Science ®Google Scholar
• Jung YJ, Kim JW, Park SJ, Min BY, Jang ES, Kim NY, Jeong SH, Shin CM, Lee SH, Park YS, et al. c-Myc-mediated overexpression of miR-17-92 suppresses replication of hepatitis B virus in human hepatoma cells. J Med Virol 2013; 85:969-78; PMID:23532756; https://doi.org/10.1002/jmv.23534
   PubMed Web of Science ®Google Scholar
• Quasdorff M, Protzer U. Control of hepatitis B virus at the level of transcription. J Viral Hepat 2010; 17:527-36; PMID:20546497; https://doi.org/10.1111/j.1365-2893.2010.01315.x
   PubMed Web of Science ®Google Scholar
• Zhang XY, Zhang EJ, Ma ZY, Pei RJ, Jiang M, Schlaak JF, Roggendorf M, Lu MJ. Modulation of hepatitis B virus replication and hepatocyte differentiation by MicroRNA-1. Hepatology 2011; 53:1476-85; PMID:21520166; https://doi.org/10.1002/hep.24195
   PubMed Web of Science ®Google Scholar
• Wang SF, Qiu LP, Yan XL, Jin WS, Wang YZ, Chen LZ, Wu EJ, Ye X, Gao GF, Wang FS, et al. Loss of microRNA 122 expression in patients with hepatitis B enhances hepatitis B virus replication through cyclin G(1) -modulated P53 activity. Hepatology 2012; 55:730-41; PMID:22105316; https://doi.org/10.1002/hep.24809
   PubMed Web of Science ®Google Scholar
• Huang JY, Chou SF, Lee JW, Chen HL, Chen CM, Tao MH, Shih C. MicroRNA-130a can inhibit hepatitis B virus replication via targeting PGC1alpha and PPARgamma. RNA 2015; 21:385-400; PMID:25595716; https://doi.org/10.1261/rna.048744.114
   PubMed Web of Science ®Google Scholar
• Zhang XY, Liu HY, Xie ZL, Deng WY, Wu CC, Qin B, Hou JL, Lu MJ. Epigenetically regulated miR-449a enhances hepatitis B virus replication by targeting cAMPresponsive element binding protein 5 and modulating hepatocytes phenotype. Sci Rep 2016; 6:25389; PMID:27138288; https://doi.org/10.1038/srep25389
   PubMed Web of Science ®Google Scholar
• Su H, Yang JR, Xu T, Huang J, Xu L, Yuan YF, Zhuang SM. MicroRNA-101, down-regulated in hepatocellular carcinoma, promotes apoptosis and suppresses tumorigenicity. Cancer Res 2009; 69:1135-42; PMID:19155302; https://doi.org/10.1158/0008-5472.CAN-08-2886
   PubMed Web of Science ®Google Scholar
• Li D, Liu XG, Lin L, Hou J, Li N, Wang CM, Wang P, Zhang Q, Zhang P, Zhou WP, et al. MicroRNA-99a inhibits hepatocellular carcinoma growth and correlates with prognosis of hepatocellular carcinoma patients. J Biol Chem 2011; 286:36677-85; PMID:21878637; https://doi.org/10.1074/jbc.M111.270561
   PubMed Web of Science ®Google Scholar
• Zhang JF, He ML, Fu WM, Wang H, Chen LZ, Zhu X, Chen Y, Xie D, Lai P, Chen G, et al. Primate-specific miRNA-637 inhibits tumorigenesis in hepatocellular carcinoma by disrupting stat3 signaling. Hepatology 2011; 54:2137-48; PMID:21809363; https://doi.org/10.1002/hep.24595
   PubMed Web of Science ®Google Scholar
• Liang L, Wong CM, Ying Q, Fan DN, Huang S, Ding J, Yao J, Yan M, Li J, Yao M, et al. MicroRNA-125b suppressesed human liver cancer cell proliferation and metastasis by directly targeting oncogene LIN28B2. Hepatology 2010; 52:1731-40; PMID:20827722; https://doi.org/10.1002/hep.23904
   PubMed Web of Science ®Google Scholar
• Hou YY, Cao WW, Li L, Li SP, Liu T, Wan HY, Liu M, Li X, Tang H. MicroRNA-519d targets MKi67 and suppresses cell growth in the hepatocellular carcinoma cell line QGY-7703. Cancer Lett 2011; 307:182-90; PMID:21524841; https://doi.org/10.1016/j.canlet.2011.04.002
   PubMed Web of Science ®Google Scholar
• Fornari F, Milazzo M, Chieco P, Negrini M, Calin GA, Grazi GL, Pollutri D, Croce CM, Bolondi L, Gramantieri L. MiR-199a-3p regulates mTOR and c-Met to influence the doxorubicin sensitivity of human hepatocarcinoma cells. Cancer Res 2010; 70:5184-93; PMID:20501828; https://doi.org/10.1158/0008-5472.CAN-10-0145
   PubMed Web of Science ®Google Scholar
• Li FH, Zhou P, Deng WY, Wang JY, Mao RC, Zhang Y, Li J, Jie Y, Yang FF, Huang YX, et al. Serum microRNA-125b Correlates with Hepatitis B Viral Replication and Liver Necroinflammation. Clin Microbiol Infect 2016; 22: 384.e1-384.e10; PMID:26802212; https://doi.org/10.1016/j.cmi.2015.12.024
   PubMed Web of Science ®Google Scholar
• Xu N, Zhang LY, Meisgen F, Harada M, Heilborn J, Homey B, Grander D, Stahle M, Sonkoly E, Pivarcsi A. MicroRNA-125b Down-regulates Matrix Metallopeptidase 13 and Inhibits Cutaneous Squamous Cell Carcinoma Cell Proliferation, Migration, and Invasion. J Biol Chem 2012; 287:29899-908; PMID:22782903; https://doi.org/10.1074/jbc.M112.391243
   PubMed Web of Science ®Google Scholar
• Tili E, Michaille JJ, Luo Z, Volinia S, Rassenti LZ, Kipps TJ, Croce CM. The downregulation of miR-125b in chronic lymphocytic leukemias leads to metabolic adaptation of cells to a transformed state. Blood 2012; 120:2631-8; PMID:22723551; https://doi.org/10.1182/blood-2012-03-415737
   PubMed Web of Science ®Google Scholar
• Cui L, Zhou H, Zhao H, Zhou YJ, Xu RF, Xu XL, Zheng L, Xue Z, Xia W, Zhang B, et al. MicroRNA-99a induces G1-phase cell cycle arrest and suppresses tumorigenicity in renal cell carcinoma. BMC Cancer 2012; 12:546; PMID:23173671; https://doi.org/10.1186/1471-2407-12-546
   PubMed Web of Science ®Google Scholar
• Duan ZF, Choy E, Harmon D, Liu XZ, Susa M, Mankin H, Hornicek F. MicroRNA-199a-3p is downregulated in human osteosarcoma and regulates cell proliferation and migration. Mol Cancer Ther 2011; 10:1337-45; PMID:21666078; https://doi.org/10.1158/1535-7163.MCT-11-0096
   PubMed Web of Science ®Google Scholar
• Gearhart TL, Bouchard MJ. Replication of the hepatitis B virus requires a calcium-dependent HBx-induced G1 phase arrest of hepatocytes. Virology 2010; 407:14-25; PMID:20719353; https://doi.org/10.1016/j.virol.2010.07.042
   PubMed Web of Science ®Google Scholar
• Henley SA, Dick FA. The retinoblastoma family of proteins and their regulatory functions in the mammalian cell division cycle. Cell Div 2012; 7:10; PMID:22417103; https://doi.org/10.1186/1747-1028-7-10
   PubMed Web of Science ®Google Scholar
• Giacinti C, Giordano A. RB and cell cycle progression. Oncogene 2006; 25:5220-7; PMID:16936740; https://doi.org/10.1038/sj.onc.1209615
   PubMed Web of Science ®Google Scholar
• Shyh-Chang N, Daley GQ. Lin28: primal regulator of growth and metabolism in stem cells. Cell Stem Cell 2013; 12:395-406; PMID:23561442; https://doi.org/10.1016/j.stem.2013.03.005
   PubMed Web of Science ®Google Scholar
• Piskounova E, Polytarchou C, Thornton JE, LaPierre RJ, Pothoulakis C, Hagan JP, Iliopoulos D, Gregory RI. Lin28A and Lin28B inhibit let-7 microRNA biogenesis by distinct mechanisms. Cell 2011; 147:1066-79;PMID:22118463;https://doi.org/10.1016/j.cell.2011.10.039
   PubMed Web of Science ®Google Scholar
• Zhu H, Shyh-Chang N, Segre AV, Shinoda G, Shah SP, Einhorn WS, Takeuchi A, Engreitz JM, Hagan JP, Kharas MG, et al. The Lin28/let-7 axis regulates glucose metabolism. Cell 2011; 147:81-94; PMID:21962509; https://doi.org/10.1016/j.cell.2011.08.033
   PubMed Web of Science ®Google Scholar
• Su JL, Chen PS, Johansson G, Kuo ML. Function and regulation of let-7 family microRNAs. Microrna 2012; 1:34-9; PMID:25048088; https://doi.org/10.2174/2211536611201010034
   PubMedGoogle Scholar
• Winther TN, Bang-Berthelsen CH, Heiberg IL, Pociot F, Hogh B. Differential Plasma MicroRNA Profiles in HBeAg Positive and HBeAg Negative Children with Chronic Hepatitis B. PLoS One 2013; 8:e58236; PMID:23469271;https://doi.org/10.1371/journal.pone.0058236
   PubMed Web of Science ®Google Scholar
• Akamatsu S, Hayes CN, Tsuge M, Miki D, Akiyama R, Abe H, Ochi H, Hiraga N, Imamura M, Takahashi S, et al. Differences in serum microRNA profiles in hepatitis B and C virus infection. The Journal of infection 2015; 70:273-87; PMID:25452043; https://doi.org/10.1016/j.jinf.2014.10.017
   PubMed Web of Science ®Google Scholar
• Brunetto MR, Cavallone D, Oliveri F, Moriconi F, Colombatto P, Coco B, Ciccorossi P, Rastelli C, Romagnoli V, Cherubini B, et al. A serum microRNA signature is associated with the immune control of chronic hepatitis B virus infection. PLoS One 2014; 9:e110782; PMID:25350115; https://doi.org/10.1371/journal.pone.0110782
   PubMed Web of Science ®Google Scholar
• Giray BG, Emekdas G, Tezcan S, Ulger M, Serin MS, Sezgin O, Altintas E, Tiftik EN. Profiles of serum microRNAs; miR-125b-5p and miR223-3p serve as novel biomarkers for HBV-positive hepatocellular carcinoma. Mol Biol Rep 2014; 41:4513-9; PMID:24595450; https://doi.org/10.1007/s11033-014-3322-3
   PubMed Web of Science ®Google Scholar
• Wittkop L, Schwarz A, Cassany A, Grun-Bernhard S, Delaleau M, Rabe B, Cazenave C, Gerlich W, Glebe D, Kann M. Inhibition of protein kinase C phosphorylation of hepatitis B virus capsids inhibits virion formation and causes intracellular capsid accumulation. Cell Microbiol 2010; 12:962-75; PMID:20109160; https://doi.org/10.1111/j.1462-5822.2010.01444.x
   PubMed Web of Science ®Google Scholar
• Ludgate L, Ning X, Nguyen DH, Adams C, Mentzer L, Hu J. Cyclin-Dependent Kinase 2 Phosphorylates S/T-P Sites in Hepadnavirus Core Protein C-terminal Domain and Is Incorporated into Viral Capsids. J Virol 2012; 86:12237-50; PMID:22951823; https://doi.org/10.1128/JVI.01218-12
   PubMed Web of Science ®Google Scholar
• Wang JC, Dhason MS, Zlotnick A. Structural organization of pregenomic RNA and the carboxy-terminal domain of the capsid protein of hepatitis B virus. PLoS Pathog 2012; 8:e1002919; PMID:23028319; https://doi.org/10.1371/journal.ppat.1002919
   PubMed Web of Science ®Google Scholar
• Ludgate L, Adams C, Hu JM. Phosphorylation state-dependent interactions of hepadnavirus core protein with host factors. PLoS One 2011; 6:e29566; PMID:22216318; https://doi.org/10.1371/journal.pone.0029566
   PubMed Web of Science ®Google Scholar
• Surdziel E, Cabanski M, Dallmann I, Lyszkiewicz M, Krueger A, Ganser A, Scherr M, Eder M. Enforced expression of miR-125b affects myelopoiesis by targeting multiple signaling pathways. Blood 2011; 117:4338-48; PMID:21368288; https://doi.org/10.1182/blood-2010-06-289058
   PubMed Web of Science ®Google Scholar
• Alpini G, Glaser SS, Zhang JP, Francis H, Han Y, Gong J, Stokes A, Francis T, Hughart N, Hubble L, et al. Regulation of placenta growth factor by microRNA-125b in hepatocellular cancer. J Hepatol 2011; 55:1339-45; PMID:21703189; https://doi.org/10.1016/j.jhep.2011.04.015
   PubMed Web of Science ®Google Scholar
• Ma XY, Li CC, Sun LC, Huang D, Li TT, He XP, Wu GW, Yang Z, Zhong XY, Song LB, et al. Lin28/let-7 axis regulates aerobic glycolysis and cancer progression via PDK1. Nat Commun 2014; 5:5212; PMID:25301052; https://doi.org/10.1038/ncomms6212
   PubMed Web of Science ®Google Scholar
• Lozier AM, Rich ME, Grawe AP, Peck AS, Zhao P, Chang AT, Bond JP, Sholler GS. Targeting ornithine decarboxylase reverses the LIN28/Let-7 axis and inhibits glycolytic metabolism in neuroblastoma. Oncotarget 2015; 6:196-206; PMID:25415050; https://doi.org/10.18632/oncotarget.2768
   PubMed Web of Science ®Google Scholar
• Ma X, Li C, Sun L, Huang D, Li T, He X, Wu G, Yang Z, Zhong X, Song L, et al. Lin28/let-7 axis regulates aerobic glycolysis and cancer progression via PDK1. Nat Commun 2014; 5:5212; PMID:25301052; https://doi.org/10.1038/ncomms6212
   PubMed Web of Science ®Google Scholar
• Dubinsky AN, Dastidar SG, Hsu CL, Zahra R, Djakovic SN, Duarte S, Esau CC, Spencer B, Ashe TD, Fischer KM, et al. Let-7 coordinately suppresses components of the amino acid sensing pathway to repress mTORC1 and induce autophagy. Cell Metab 2014; 20:626-38; PMID:25295787; https://doi.org/10.1016/j.cmet.2014.09.001
   PubMed Web of Science ®Google Scholar
• Tian Y, Sir D, Kuo CF, Ann DK, Ou JH. Autophagy required for hepatitis B virus replication in transgenic mice. J Virol 2011; 85:13453-6; PMID:21957292; https://doi.org/10.1128/JVI.06064-11
   PubMed Web of Science ®Google Scholar
• Sir D, Ann DK, Ou JH. Autophagy by hepatitis B virus and for hepatitis B virus. Autophagy 2010; 6:548-9; PMID:20305390; https://doi.org/10.4161/auto.6.4.11669
   PubMed Web of Science ®Google Scholar
• Li H, Zhu W, Zhang L, Lei H, Wu X, Guo L, Chen X, Wang Y, Tang H. The metabolic responses to hepatitis B virus infection shed new light on pathogenesis and targets for treatment. Sci Rep 2015; 5:8421; PMID:25672227; https://doi.org/10.1038/srep08421
   PubMed Web of Science ®Google Scholar
• Lin Y, Deng W, Pang J, Kemper T, Hu J, Yin J, Zhang J, Lu M. The microRNA-99 family modulates hepatitis B virus replication by promoting IGF-1R/PI3K/Akt/mTOR/ULK1 signaling-induced autophagy. Cell Microbiol 2016; PMID:27886437; https://doi.org/10.1111/cmi.12709
   PubMed Web of Science ®Google Scholar
• Shlomai A, Paran N, Shaul Y. PGC-1alpha controls hepatitis B virus through nutritional signals. Proc Natl Acad Sci U S A 2006; 103:16003-8;PMID:17043229;https://doi.org/10.1073/pnas.0607837103
   PubMed Web of Science ®Google Scholar
• Wang TZ, Zhao R, Wu YQ, Kong D, Zhang L, Wu D, Li C, Zhang C, Yu ZX, Jin XM. Hepatitis B virus induces G1 phase arrest by regulating cell cycle genes in HepG2.2.15 cells. Virol J 2011; 8:231; PMID:21575146; https://doi.org/10.1186/1743-422X-8-231
   PubMed Web of Science ®Google Scholar
• Guan SH, Lu MJ, Grunewald P, Roggendorf M, Gerken G, Schlaak JF. Interferon-alpha response in chronic hepatitis B-transfected HepG2.2.15 cells is partially restored by lamivudine treatment. World J Gastroentero 2007; 13:228-35; PMID:17226901; https://doi.org/10.3748/wjg.v13.i2.228
   PubMed Web of Science ®Google Scholar
• Zhang XY, Meng ZJ, Qiu S, Xu Y, Yang DL, Schlaak JF, Roggendorf M, Lu MJ. Lipopolysaccharide-induced innate immune responses in primary hepatocytes downregulates woodchuck hepatitis virus replication via interferon-independent pathways. Cell Microbiol 2009; 11:1624-37; PMID:PMID:19573162; https://doi.org/10.1111/j.1462-5822.2009.01353.x
   PubMed Web of Science ®Google Scholar